FAQ on Nutriband Inc. CEO's Temporary Step Aside for Irish Presidential Candidacy
Summary
Nutriband Inc. CEO Gareth Sheridan temporarily steps down to run for Irish Presidency, with Chairman Serguei Melnik taking over CEO duties, while the company continues its focus on developing an abuse-deterrent fentanyl patch.
Why is Nutriband Inc.’s CEO stepping aside?
Gareth Sheridan is stepping aside temporarily to pursue candidacy in the Irish Presidential election.
Who will take over the CEO duties at Nutriband Inc. during this period?
Co-Founder and Chairman Serguei Melnik will assume CEO duties during Gareth Sheridan’s absence.
What is the duration of Gareth Sheridan’s leave from Nutriband Inc.?
Gareth Sheridan will step aside for three months.
What is Nutriband Inc.’s lead product under development?
The lead product is an abuse-deterrent fentanyl patch incorporating the AVERSA(TM) technology.
What is the significance of the AVERSA(TM) technology?
AVERSA(TM) technology is designed to prevent the abuse, misuse, diversion, and accidental exposure of drugs with abuse potential.
What are the estimated peak U.S. sales for the AVERSA Fentanyl patch?
Potential peak U.S. sales are estimated at $80 million to $200 million.
How is the AVERSA(TM) technology protected?
The technology is protected by patents in 46 countries.
What are Nutriband Inc.’s plans for the AVERSA Fentanyl patch?
The company plans to expand the availability of the AVERSA Fentanyl patch to major global medical markets.
Where can I find more information about Nutriband Inc.?
More information is available on the company’s website at www.nutriband.com and in the company’s newsroom at https://ibn.fm/NTRB.
This story is based on an article that was registered on the blockchain. The original source content used for this article is located at InvestorBrandNetwork (IBN)
Article Control ID: 145566